LEADER 03320nam 22006735 450 001 9910869176203321 005 20250807135815.0 010 $a981-9730-01-5 024 7 $a10.1007/978-981-97-3001-8 035 $a(MiAaPQ)EBC31510980 035 $a(Au-PeEL)EBL31510980 035 $a(CKB)32650211900041 035 $a(DE-He213)978-981-97-3001-8 035 $a(EXLCZ)9932650211900041 100 $a20240702d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiosimilars for Cancer Treatment $eA Promising Approach /$fedited by Shvetank Bhatt, Harish Dureja, Samir Gunvantbhai Patel, Archita Samir Patel, Kamal Dua 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (316 pages) 311 08$a981-9730-00-7 320 $aIncludes bibliographical references. 327 $a1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers. 330 $aThe book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment. 606 $aCancer 606 $aBiology 606 $aCancer$xTreatment 606 $aCancer$xPrevention 606 $aCancer$xGenetic aspects 606 $aCancer Biology 606 $aBiological Sciences 606 $aCancer Therapy 606 $aCancers 606 $aCancer Prevention 606 $aCancer Genetics and Genomics 615 0$aCancer. 615 0$aBiology. 615 0$aCancer$xTreatment. 615 0$aCancer$xPrevention. 615 0$aCancer$xGenetic aspects. 615 14$aCancer Biology. 615 24$aBiological Sciences. 615 24$aCancer Therapy. 615 24$aCancers. 615 24$aCancer Prevention. 615 24$aCancer Genetics and Genomics. 676 $a615.7 702 $aBhatt$b Shvetank 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910869176203321 996 $aBiosimilars for Cancer Treatment$94255388 997 $aUNINA LEADER 01402oam 2200409zu 450 001 9910872710303321 005 20241212215024.0 035 $a(CKB)111026746740900 035 $a(SSID)ssj0000445284 035 $a(PQKBManifestationID)12142958 035 $a(PQKBTitleCode)TC0000445284 035 $a(PQKBWorkID)10485000 035 $a(PQKB)11710496 035 $a(EXLCZ)99111026746740900 100 $a20160829d1995 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 10$aInternational Symposium on Computer Vision : proceedings, Coral Gables, Florida, November 21-23, 1995 210 31$a[Place of publication not identified]$cIEEE Computer Society Press$d1995 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780818671906 311 08$a0818671904 606 $aComputer vision$vCongresses 606 $aEngineering & Applied Sciences$2HILCC 606 $aApplied Physics$2HILCC 615 0$aComputer vision 615 7$aEngineering & Applied Sciences 615 7$aApplied Physics 676 $a006.3/7 712 02$aIEEE Computer Society Technical Committee on Pattern Analysis and Machine Intelligence. 801 0$bPQKB 906 $aBOOK 912 $a9910872710303321 996 $aInternational Symposium on Computer Vision : proceedings, Coral Gables, Florida, November 21-23, 1995$92324750 997 $aUNINA